Clinical Trials for D2M Biotherapeutics

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: D2M Biotherapeutics

Clinical Trials (1)

NCT06328673
A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors
PHASE1Recruiting
160 participants
Started: Mar 1, 2024 · Completed: Mar 1, 2026
1 condition1 sponsor2 locations